| Drug Name |
Streptozocin |
| Drug ID |
BADD_D02073 |
| Description |
An antibiotic that is produced by Stretomyces achromogenes. It is used as an antineoplastic agent and to induce diabetes in experimental animals. |
| Indications and Usage |
For the treatment of malignant neoplasms of pancreas (metastatic islet cell carcinoma). |
| Marketing Status |
approved; investigational |
| ATC Code |
L01AD04 |
| DrugBank ID |
DB00428
|
| KEGG ID |
D05932
|
| MeSH ID |
D013311
|
| PubChem ID |
29327
|
| TTD Drug ID |
D0I8RR
|
| NDC Product Code |
67430-225; 68118-100; 0703-4636 |
| UNII |
5W494URQ81
|
| Synonyms |
Streptozocin | Streptozotocine | 2-Deoxy-2-((methylnitrosoamino)carbonyl)amino-D-glucose | Streptozotocin | Zanosar |
